A new imaging molecule that can detect and map plaques and tangles in the brains of people with Alzheimer's disease could eventually lead to earlier diagnosis of the devastating disease, researchers at the University of California, Los Angeles report in the New England Journal of Medicine. The compound, developed by UCLA and called FDDNP, also holds promise as a research tool to evaluate new treatments for Alzheimer's. [click link for full article]
FULL STORY

Source: Seniors / Aging News From Medical News Today